What the EWSR1-ATF1 fusion has taught us about hyalinizing clear cell carcinoma

Head Neck Pathol. 2013 Mar;7(1):28-34. doi: 10.1007/s12105-013-0427-2. Epub 2013 Mar 5.

Abstract

Hyalinizing clear cell carcinoma (HCCC) is a unique low-grade tumor composed of cords and nests of clear cells in a hyalinized stroma that was first reported by Milchgrub et al. It was recognized as a separate entity from clear cell variants of epithelial-myoepithelial carcinoma, myoepithelial carcinoma and mucoepidermoid carcinoma. HCCC is included in a long list of clear cell-containing tumors of salivary gland, as well as odontogenic tumors and metastases (renal cell carcinoma). Up until now, it has been considered a diagnosis of exclusion, despite its very distinctive appearance, and labeled as "not otherwise specified" by the World Health Organization. The emergence of molecular data in salivary gland tumors, including HCCC now allow for a more rigorous appraisal of its spectrum. The EWSR1-ATF1 fusion has proven the concept of a "mucinous HCCC" and removes mucin as an exclusion criterion for this tumor. It has also proven a genetic link between clear cell odontogenic carcinoma and HCCC. Molecularly-proven cases have also highlighted variant morphologies and shown that cases with overt squamous differentiation are true HCCC. This gives further weight to the classification of this tumor as squamous or adenosquamous in differentiation and as a specific entity rather than an "NOS" tumor.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma, Clear Cell / classification*
  • Adenocarcinoma, Clear Cell / diagnosis
  • Adenocarcinoma, Clear Cell / genetics*
  • Head and Neck Neoplasms / classification*
  • Head and Neck Neoplasms / diagnosis
  • Head and Neck Neoplasms / genetics*
  • Humans
  • Hyalin
  • Oncogene Proteins, Fusion / genetics*

Substances

  • EWSR1-ATF1 fusion protein, human
  • Oncogene Proteins, Fusion